ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AAZ Anglo Asian Mining Plc

89.50
2.90 (3.35%)
Last Updated: 15:50:48
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Anglo Asian Mining Plc LSE:AAZ London Ordinary Share GB00B0C18177 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.90 3.35% 89.50 87.00 92.00 92.00 83.50 83.50 164,919 15:50:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 45.86M -24.24M -0.2122 -4.34 98.93M
Anglo Asian Mining Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker AAZ. The last closing price for Anglo Asian Mining was 86.60p. Over the last year, Anglo Asian Mining shares have traded in a share price range of 36.50p to 92.00p.

Anglo Asian Mining currently has 114,242,024 shares in issue. The market capitalisation of Anglo Asian Mining is £98.93 million. Anglo Asian Mining has a price to earnings ratio (PE ratio) of -4.34.

Anglo Asian Mining Share Discussion Threads

Showing 83926 to 83950 of 147975 messages
Chat Pages: Latest  3363  3362  3361  3360  3359  3358  3357  3356  3355  3354  3353  3352  Older
DateSubjectAuthorDiscuss
15/9/2020
19:54
Sorry after the weekend discussion I thought I would post this BBC article to show the bias and extreme negativity this news outlet has. After a long preamble of what a disaster CV19 testing is in the UK and how the government are failing miserably they actually post something that would quite easily have been the headline and put a positive light on life in the UK and make people actually feel like we are in not such a bad way but its a few lines from the bottom of a long article so well hidden. Really and truly disgusting how they are twisting things. I am not a Tory voter by the way.

'But this is not unique to the UK. Other countries are facing similar pressures. In fact, the UK is testing more people per head of population than Spain, France and Germany.'

pogue
15/9/2020
19:47
That PXC chart wan, looks like history repeating itself with current move very similar to the 27-42 leg up. So it should be something like 40-60 though subject always to news. My spreadbet account is up 40% in 2 days. I'm taking some cash out so there's no risk of giving it all back. In March I had a £600 per point position on AVCT at 16p...had I held to £2 I would have made 6 figures, tax free. Instead I was squeezed day after day for margin and ended up being a forced seller of most at the bottom (when often you couldn't sell more than the equivalent of 3000 shares - £500 - at a time). You live and learn but I'm not trying to grow my SB account but instead harvest cash from it. When you win at the casino don't give it all back
mad foetus
15/9/2020
19:36
Trinity ended up 17% after a slow start think news got digested then the buying started, finished with nice large buy candle end of days play.
BUY from the Investors Chronicle - "material upside to my conservative 12p target price.

avsome1968
15/9/2020
18:03
Actually ended up quite funny.One half of me suspected that you didn't know the answers to my questions any more than I did.Rather poorly blustering your way out of it. I am genuinely surprised that what is involved in the tunnelling hasn't caused more debate.Another question. How many more meters to go?
klosters65
15/9/2020
17:47
EVG - yep, think that's a 500K shares buy from 11.11am today, reported after the bell Rb :-) Cheers Wan :-)

edit,,, oh, hang on a mo, is that actually a sell !!!!???? grr LOL

wanobi
15/9/2020
17:31
PXC chart, whatever way you look at it,,,,, that's some breakout :-) GLA Holders and very. very well done,,, cheers Wan :-)


free stock charts from uk.advfn.com

wanobi
15/9/2020
17:17
klosters65 sorry if that came across like that, it wasn't meant to ridicule you, was just having a bit of fun while we wait for news.

I was also wondering about the incline of the tunnel as well, is it a shaft or something that they can lay tracks on. Also does the rock from where the tunnel will be excavated have any commercial gold grades in it?

katsy
15/9/2020
16:39
funny old day :-) LOL Cheers Wan :-)

EVG !!

wishing you all a fine evening :-)

wanobi
15/9/2020
16:29
Had a excellent day with DDDD, PXC and TXP. Even CEY worked hard to-day.
swallowsflysouth
15/9/2020
16:17
No stopping PXC for sure
riggerbeautz
15/9/2020
16:09
Not you,Goldfinger. I wanted to learn about the tunnel. For some reason Katsy took it upon himself to ridicule me. Seems out of character. I think, a few of us long term holders have simply been worn down by the waiting. Water under the bridge now.
klosters65
15/9/2020
15:58
yep, that's great to see qaz :-) LOL Cheers Wan :-)
wanobi
15/9/2020
15:57
I think so to Rb, seems we have a Mr 350K there :-) LOL cheers Wan :-)
wanobi
15/9/2020
15:45
Fairly certain EVG selling is also being bought.
riggerbeautz
15/9/2020
15:24
PXC and DDDD both absolutely flying today :-)
qazwsxedc69
15/9/2020
15:19
EVG,,, there you go chaps, told you I was talking utter rubbish :-) LOL,,,, a lot of selling on that positive news :-) LOL,,, oh well, back to waiting :-) GLA Cheers Wan :-)
wanobi
15/9/2020
14:42
Katsy. Mum's the word.
AAZ interim results tomorrow?
Should be some statement on the state of play with Conroy Gold.
Conroy Gold (CGNR) Mkt cap is only £9 million.
You would think if anyone could prove commerciality of this discovery, Stephen Westhead could.
Could be worth an investment in its own right if AAZ ratify JV.
Insiders incl Prof Conroy seem to think it's going ahead?

Twitter today:


A comment by Paul Johnson a major holder with 6.43% of the company. (Paul and Michelle Johnson: 1,686,255 (6.43%)

“Of course we are waiting for the full JV to be announced however worth investors taking a close look at #CGNR - targeting 9m ounces at Clontibret/Clay Lake with 517,000 ounces gold already defined. Fosterville type mineralisation - am looking for the deeper drills!”

stevea171
15/9/2020
14:10
Does anybody know if they've began anything at Conroy gold yet, even put in an application to drill, anything?
katsy
15/9/2020
14:02
Trust they'll maintain the divi at 25% of FCF.
goodgrief
15/9/2020
13:58
Just need good, positive, unambiguous news. No more playing down expectations or under promising. Just having a fast track to make as much money as possible while the tailwinds are so strong. Upping production must be the top priority.
donald pond
15/9/2020
13:50
pog must be averaging over $1,850 to date. 25% ahead of assumptions! Pretty amazing
mattjos
15/9/2020
13:28
many thanx Stig, cheers Wan :-)
wanobi
15/9/2020
13:19
This is a quite extraordinarily bullish piece quoting the Company just days before release of a major news item (Phase II Clinical Trial readout on IBS product Blautix). Can only imagine the Company are supremely confident they have news up their sleeve to get the share price up prior to NASDAQ listing in Q1 2021? When they should be valued AT LEAST on a par with Seres Therapeutics (Mkt Cap : $2.4bn) vs 4D (Mkt Cap : $240m)




Imagine you find yourself in a lift with Warren Buffett. What would be your ‘elevator pitch’ to summarise why he should invest in your business?

Live Biotherapeutics are a paradigm shift in medicine, a whole new class of drug much like the emergence of biologics and gene therapies. It is important to emphasise that Live Biotherapeutics are not a distant goal or immature concept, they are here and now, delivering game-changing clinical data and changing patients’ lives.

4D pharma is leading this rapidly emerging field, driven by its ‘function-first’ ethos and unparalleled platform technology, MicroRx. The platform has to date generated four unique clinical-stage Live Biotherapeutic drug candidates across a range of therapeutic areas, and a suite of pre-clinical programmes in new diseases. 4D is pushing the boundaries of the field, taking the microbiome beyond the gut in fields like oncology and neuroscience.

4D is best positioned to deliver on the promise of Live Biotherapeutics as the only truly end-to-end player in this exciting field. 4D pharma’s in-house capabilities cover the drug development spectrum, from discovery through manufacturing, IP protection, regulatory and clinical development.

Together these factors clearly demonstrate there is huge near- and long-term upside in 4D pharma, both from our development candidates currently in the clinic in major diseases with significant unmet need, but also in the MicroRx platform that drives us and our collaborations.

the stigologist
15/9/2020
13:13
Klosters

I take it your "Pathetic" post referred to my post?

Was it all Pathetic or just some of it?

gold finger 1
15/9/2020
13:07
Maybe some antics tomorrow with FOMC.
brasso3
Chat Pages: Latest  3363  3362  3361  3360  3359  3358  3357  3356  3355  3354  3353  3352  Older

Your Recent History

Delayed Upgrade Clock